| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology, Psychiatry and Biobehavioral Sciences(Dr. Cummings), and Pathology and Laboratory Medicine (Neuropathology Division) (Dr. Vinters), University of California at Los Angeles School of Medicine, CA; the Medicine Service, Sepulveda Veterans Affairs Medical Center (Dr. Cole), Sepulveda, CA; and Khachaturian, Radebaugh, & Associates, Inc. (Dr. Khachaturian), Potomac, MD.
Address correspondence and reprint requests to Dr. Jeffrey L. Cummings, UCLA Department of Neurology, 710 Westwood Plaza, Los Angeles, CA 90095-1769.
Abstract.
Alzheimer's disease (AD) can be diagnosed with a considerable degree of accuracy. In some centers, clinical diagnosis predicts the autopsy diagnosis with 90% certainty in series reported from academic centers. The characteristic histopathologic changes at autopsy include neurofibrillary tangles, neuritic plaques, neuronal loss, and amyloid angiopathy. Mutations on chromosomes 21, 14, and 1 cause familial AD. Risk factors for AD include advanced age, lower intelligence, small head size, and history of head trauma; female gender may confer additional risks. Susceptibility genes do not cause the disease by themselves but, in combination with other genes or epigenetic factors, modulate the age of onset and increase the probability of developing AD. Among several putative susceptibility genes (on chromosomes 19, 12, and 6), the role of apolipoprotein E (ApoE) on chromosome 19 has been repeatedly confirmed. Protective factors include ApoE-2 genotype, history of estrogen replacement therapy in postmenopausal women, higher educational level, and history of use of nonsteroidal anti-inflammatory agents. The most proximal brain events associated with the clinical expression of dementia are progressive neuronal dysfunction and loss of neurons in specific regions of the brain. Although the cascade of antecedent events leading to the final common path of neurodegeneration must be determined in greater detail, the accumulation of stable amyloid is increasingly widely accepted as a central pathogenetic event. All mutations known to cause AD increase the production of β-amyloid peptide. This protein is derived from amyloid precursor protein and, when aggregated in a β-pleated sheet configuration, is neurotoxic and forms the core of neuritic plaques. Nerve cell loss in selected nuclei leads to neurochemical deficiencies, and the combination of neuronal loss and neurotransmitter deficits leads to the appearance of the dementia syndrome. The destructive aspects include neurochemical deficits that disrupt cell-to-cell communications, abnormal synthesis and accumulation of cytoskeletal proteins (e.g., 
), loss of synapses, pruning of dendrites, damage through oxidative metabolism, and cell death. The concepts of cognitive reserve and symptom thresholds may explain the effects of education, intelligence, and brain size on the occurrence and timing of AD symptoms. Advances in understanding the pathogenetic cascade of events that characterize AD provide a framework for early detection and therapeutic interventions, including transmitter replacement therapies, antioxidants, anti-inflammatory agents, estrogens, nerve growth factor, and drugs that prevent amyloid formation in the brain.
This article has been cited by other articles:
|
|
 |
|
  J. J. Jalbert, L. A. Daiello, and K. L. Lapane Dementia of the Alzheimer Type Epidemiol. Rev., November 1, 2008; 30(1): 15 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Koepsell, B. F. Kurland, O. Harel, E. A. Johnson, X. -H. Zhou, and W. A. Kukull Education, cognitive function, and severity of neuropathology in Alzheimer disease Neurology, May 6, 2008; 70(19_Part_2): 1732 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Rajput, H. H. Sitte, A. Rajput, M. E. Fenton, C. Pifl, and O. Hornykiewicz Globus pallidus dopamine and Parkinson motor subtypes: Clinical and brain biochemical correlation Neurology, April 15, 2008; 70(16_Part_2): 1403 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter PNAS, March 18, 2008; 105(11): 4405 - 4410.
|
|
|
|
 |
|
 C. A. Yury and J. E. Fisher Preventing Excess Disability in an Elderly Person With Alzheimer's Disease Clinical Case Studies, August 1, 2007; 6(4): 295 - 306. [Abstract] [PDF]
|
|
|
|
 |
|
 G. A. Marshall, L. A. Fairbanks, S. Tekin, H. V. Vinters, and J. L. Cummings Early-Onset Alzheimer's Disease Is Associated With Greater Pathologic Burden J Geriatr Psychiatry Neurol, March 1, 2007; 20(1): 29 - 33. [Abstract] [PDF]
|
|
|
|
 |
|
 O. Stuve, C. M. Marra, P. D. Cravens, M. P. Singh, W. Hu, A. Lovett-Racke, N. L. Monson, J. T. Phillips, J. W. C. Tervaert, R. A. Nash, et al. Potential Risk of Progressive Multifocal Leukoencephalopathy With Natalizumab Therapy: Possible Interventions Arch Neurol, February 1, 2007; 64(2): 169 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Criado, C. Amo, P. Quint, L. Kurelowech, and S. M. Otis Using Magnetoencephalography to Study Patterns of Brain Magnetic Activity in Alzheimer's Disease American Journal of Alzheimer's Disease and Other Dementias, January 1, 2007; 21(6): 416 - 423. [Abstract] [PDF]
|
|
|
|
|
|
T. D. Sotnikova, M. G. Caron, and R. R. Gainetdinov DDD mice, a novel acute mouse model of Parkinson's disease. Neurology, October 10, 2006; 67(7 Suppl 2): S12 - S17. [Abstract] [Full Text]
|
|
|
|
|
|
C. Caccia, R. Maj, M. Calabresi, S. Maestroni, L. Faravelli, L. Curatolo, P. Salvati, and R. G. Fariello Safinamide: from molecular targets to a new anti-Parkinson drug. Neurology, October 10, 2006; 67(7 Suppl 2): S18 - S23. [Abstract] [Full Text]
|
|
|
|
|
|
D. A. Bennett, J. A. Schneider, Z. Arvanitakis, J. F. Kelly, N. T. Aggarwal, R. C. Shah, and R. S. Wilson Neuropathology of older persons without cognitive impairment from two community-based studies Neurology, June 27, 2006; 66(12): 1837 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Quik, L. Chen, N. Parameswaran, X. Xie, J. W. Langston, and S. E. McCallum Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates. J. Neurosci., April 26, 2006; 26(17): 4681 - 4689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Tofaris, P. Garcia Reitbock, T. Humby, S. L. Lambourne, M. O'Connell, B. Ghetti, H. Gossage, P. C. Emson, L. S. Wilkinson, M. Goedert, et al. Pathological Changes in Dopaminergic Nerve Cells of the Substantia Nigra and Olfactory Bulb in Mice Transgenic for Truncated Human {alpha}-Synuclein(1-120): Implications for Lewy Body Disorders J. Neurosci., April 12, 2006; 26(15): 3942 - 3950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Rapp, M. Schnaider-Beeri, H. T. Grossman, M. Sano, D. P. Perl, D. P. Purohit, J. M. Gorman, and V. Haroutunian Increased Hippocampal Plaques and Tangles in Patients With Alzheimer Disease With a Lifetime History of Major Depression Arch Gen Psychiatry, February 1, 2006; 63(2): 161 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Andel, M. Crowe, N. L. Pedersen, J. Mortimer, E. Crimmins, B. Johansson, and M. Gatz Complexity of Work and Risk of Alzheimer's Disease: A Population-Based Study of Swedish Twins J. Gerontol. B. Psychol. Sci. Soc. Sci., September 1, 2005; 60(5): P251 - P258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. McCallum, N. Parameswaran, T. Bordia, J. M. McIntosh, S. R. Grady, and M. Quik Decrease in {alpha}3*/{alpha}6* Nicotinic Receptors but Not Nicotine-Evoked Dopamine Release in Monkey Brain after Nigrostriatal Damage Mol. Pharmacol., September 1, 2005; 68(3): 737 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bunce, M. Kivipelto, and A. Wahlin Apolipoprotein E, B Vitamins, and Cognitive Function in Older Adults J. Gerontol. B. Psychol. Sci. Soc. Sci., May 1, 2005; 60(1): P41 - P48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Zoccarato, P. Toscano, and A. Alexandre Dopamine-derived Dopaminochrome Promotes H2O2 Release at Mitochondrial Complex I: STIMULATION BY ROTENONE, CONTROL BY Ca2+, AND RELEVANCE TO PARKINSON DISEASE J. Biol. Chem., April 22, 2005; 280(16): 15587 - 15594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Huitron-Resendiz, M. Sanchez-Alavez, and J. R. Criado Sleep-wake states ub transgenic mouse models overexpressing the human {beta}-amyloid precursor protein American Journal of Alzheimer's Disease and Other Dementias, March 1, 2005; 20(2): 87 - 90. [Abstract] [PDF]
|
|
|
|
|
|
F. Yang, G. P. Lim, A. N. Begum, O. J. Ubeda, M. R. Simmons, S. S. Ambegaokar, P. P. Chen, R. Kayed, C. G. Glabe, S. A. Frautschy, et al. Curcumin Inhibits Formation of Amyloid {beta} Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo J. Biol. Chem., February 18, 2005; 280(7): 5892 - 5901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Murrell, N. L. Salsman, and S. Meeks Positive and Negative Psychological States and Economic Status as Mediators of the Relationship of Education to Fatigue Among Older Adults Research on Aging, November 1, 2004; 26(6): 673 - 700. [Abstract] [PDF]
|
|
|
|
|
|
J. P. Kelly, C. M. Filley, R. S. Wilson, and D. A. Bennett Proneness to psychological distress is associated with risk of Alzheimer's disease Neurology, September 14, 2004; 63(5): 941 - 941. [Full Text] [PDF]
|
|
|
|
 |
|
 E. van Mirre, J. L. Teeling, J. W. M. van der Meer, W. K. Bleeker, and C. E. Hack Monomeric IgG in Intravenous Ig Preparations Is a Functional Antagonist of Fc{gamma}RII and Fc{gamma}RIIIb J. Immunol., July 1, 2004; 173(1): 332 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakagawa, M. Ohgoh, Y. Nishizawa, and H. Ogura Dopaminergic Agonists and Muscarinic Antagonists Improve Lateralization in Hemiparkinsonian Rats in a Novel Exploratory Y-Maze J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 737 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Kalivendi, S. Cunningham, S. Kotamraju, J. Joseph, C. J. Hillard, and B. Kalyanaraman {alpha}-Synuclein Up-regulation and Aggregation during MPP+-induced Apoptosis in Neuroblastoma Cells: INTERMEDIACY OF TRANSFERRIN RECEPTOR IRON AND HYDROGEN PEROXIDE J. Biol. Chem., April 9, 2004; 279(15): 15240 - 15247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Luellen, D. B. Miller, A. C. Chisnell, D. L. Murphy, J. P. O'Callaghan, and A. M. Andrews Neuronal and Astroglial Responses to the Serotonin and Norepinephrine Neurotoxin: 1-Methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 923 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Murrell, N. L. Salsman, and S. Meeks Educational Attainment, Positive Psychological Mediators, and Resources for Health and Vitality in Older Adults J Aging Health, November 1, 2003; 15(4): 591 - 615. [Abstract] [PDF]
|
|
|
|
|
|
R.S. Wilson, D.A. Bennett, J.L. Bienias, C.F. Mendes de Leon, M.C. Morris, and D.A. Evans Cognitive activity and cognitive decline in a biracial community population Neurology, September 23, 2003; 61(6): 812 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Rosenthal and N. Khotianov Managing Alzheimer Dementia Tomorrow J Am Board Fam Med, September 1, 2003; 16(5): 423 - 434. [Abstract] [Full Text]
|
|
|
|
|
|
M. Crowe, R. Andel, N. L. Pedersen, B. Johansson, and M. Gatz Does Participation in Leisure Activities Lead to Reduced Risk of Alzheimer's Disease? A Prospective Study of Swedish Twins J. Gerontol. B. Psychol. Sci. Soc. Sci., September 1, 2003; 58(5): P249 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Katz, C. M. Hivnor, D. E. Geist, M. Shapiro, M. E. Ming, and V. P. Werth Stroke and Deep Venous Thrombosis Complicating Intravenous Immunoglobulin Infusions Arch Dermatol, August 1, 2003; 139(8): 991 - 993. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Fuller and I. Bone NEUROMUSCULAR DISEASE J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(90002): ii1 - 2. [Full Text] [PDF]
|
|
|
|
|
|
C. Dufouil, A. Alperovitch, and C. Tzourio Influence of education on the relationship between white matter lesions and cognition Neurology, March 11, 2003; 60(5): 831 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Doder, E. A. Rabiner, N. Turjanski, A. J. Lees, and D. J. Brooks Tremor in Parkinson's disease and serotonergic dysfunction: An 11C-WAY 100635 PET study Neurology, February 25, 2003; 60(4): 601 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Takahashi, T. Takata, M. Hoshino, M. Sakurai, and I. Kanazawa Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjogren's syndrome Neurology, February 11, 2003; 60(3): 503 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Teel and P. Carson Family Experiences in the Journey Through Dementia Diagnosis and Care Journal of Family Nursing, February 1, 2003; 9(1): 38 - 58. [Abstract] [PDF]
|
|
|
|
 |
|
 F.-M. Zhou, C. Wilson, and J. A. Dani Muscarinic and Nicotinic Cholinergic Mechanisms in the Mesostriatal Dopamine Systems Neuroscientist, February 1, 2003; 9(1): 23 - 36. [Abstract] [PDF]
|
|
|
|
 |
|
 J. R. Petrella, R. E. Coleman, and P. M. Doraiswamy Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future Radiology, February 1, 2003; 226(2): 315 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Unger, P. Mazzola-Pomietto, D. L. Murphy, and A. M. Andrews 2'-NH2-MPTP [1-Methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] Depletes Serotonin and Norepinephrine in Rats: A Comparison with 2'-CH3-MPTP [1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine] J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 527 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Murrell and S. Meeks Psychological, Economic, and Social Mediators of the Education-Health Relationship in Older Adults J Aging Health, November 1, 2002; 14(4): 527 - 550. [Abstract] [PDF]
|
|
|
|
|
|
J. Lotharius, S. Barg, P. Wiekop, C. Lundberg, H. K. Raymon, and P. Brundin Effect of Mutant alpha -Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line J. Biol. Chem., October 4, 2002; 277(41): 38884 - 38894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lotharius and P. Brundin Impaired dopamine storage resulting from {alpha}-synuclein mutations may contribute to the pathogenesis of Parkinson's disease Hum. Mol. Genet., October 1, 2002; 11(20): 2395 - 2407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Wight, C. S. Aneshensel, and T. E. Seeman Educational Attainment, Continued Learning Experience, and Cognitive Function among Older Men J Aging Health, May 1, 2002; 14(2): 211 - 236. [Abstract] [PDF]
|
|
|
|
|
|
M Stangel and H-P Hartung Despair of repair J. Neurol. Neurosurg. Psychiatry, January 1, 2002; 72(1): 1 - 4. [Full Text] [PDF]
|
|
|
|
|
|
R. O'Hara, J. M. Thompson, H. C. Kraemer, C. Fenn, J. L. Taylor, L. Ross, J. A. Yesavage, A. M. Bailey, and J. R. Tinklenberg Which Alzheimer Patients Are at Risk for Rapid Cognitive Decline? J Geriatr Psychiatry Neurol, January 1, 2002; 15(4): 233 - 238. [Abstract] [PDF]
|
|
|
|
 |
|
 M. A. Boyd Behavioral Disturbances Associated with Dementia: Nursing Implications Journal of the American Psychiatric Nurses Association, December 1, 2001; 7(6): S14 - S22. [Abstract] [PDF]
|
|
|
|
 |
|
 F. M. S. DE VRIJ, J. A. SLUIJS, L. GREGORI, D. F. FISCHER, W. T. J. M. C. HERMENS, D. GOLDGABER, J. VERHAAGEN, F. W. VAN LEEUWEN, and E. M. HOL Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death1 FASEB J, December 1, 2001; 15(14): 2680 - 2688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. K. Bleeker, J. L. Teeling, and C. E. Hack Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect Blood, November 15, 2001; 98(10): 3136 - 3142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. LIN, R. BHATIA, and R. LAL Amyloid {beta} protein forms ion channels: implications for Alzheimer's disease pathophysiology FASEB J, November 1, 2001; 15(13): 2433 - 2444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N P S BAJAJ, N HENDERSON, R BAHL, K STOTT, and R E CLIFFORD-JONES Call for guidelines for monitoring renal function and haematological variables during intravenous infusion of immunoglobulin in neurological patients J. Neurol. Neurosurg. Psychiatry, October 1, 2001; 71(4): 562 - 563. [Full Text]
|
|
|
|
|
|
M. Gatz, P. Svedberg, N. L. Pedersen, J. A. Mortimer, S. Berg, and B. Johansson Education and the Risk of Alzheimer's Disease: Findings From the Study of Dementia in Swedish Twins J. Gerontol. B. Psychol. Sci. Soc. Sci., September 1, 2001; 56(5): P292 - 300. [Abstract] [Full Text]
|
|
|
|
|
|
H. Petrovitch, L.R. White, G.W. Ross, S.C. Steinhorn, C.Y. Li, K.H. Masaki, D.G. Davis, J. Nelson, J. Hardman, J.D. Curb, et al. Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study Neurology, July 24, 2001; 57(2): 226 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Cummings, A. Nadel, D. Masterman, and P. A. Cyrus Efficacy of Metrifonate in Improving the Psychiatric and Behavioral Disturbances of Patients with Alzheimer's Disease J Geriatr Psychiatry Neurol, June 1, 2001; 14(2): 101 - 108. [Abstract] [PDF]
|
|
|
|
 |
|
 S Genevay, A Saudan-Kister, and P-A Guerne Intravenous gammaglobulins in refractory polymyositis: lower dose for maintenance treatment is effective Ann Rheum Dis, June 1, 2001; 60(6): 635 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. S. LEE, F. LIU, Z. B. PRISTUPA, and H. B. NIZNIK Direct binding and functional coupling of {alpha}-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis FASEB J, April 1, 2001; 15(6): 916 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Takenoshita, M Shizuka-Ikeda, H Mitoma, S-Y Song, Y Harigaya, Y Igeta, M Yaguchi, K Ishida, M Shoji, M Tanaka, et al. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia J. Neurol. Neurosurg. Psychiatry, March 1, 2001; 70(3): 386 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Bigler, C. M. Lowry, C. V. Anderson, S. C. Johnson, J. Terry, and M. Steed Dementia, Quantitative Neuroimaging, and Apolipoprotein E Genotype AJNR Am. J. Neuroradiol., November 1, 2000; 21(10): 1857 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bowirrat, R. P. Friedland, J. Chapman, and A. D. Korczyn The very high prevalence of AD in an Arab population is not explained by APOE {{epsilon}}4 allele frequency Neurology, September 12, 2000; 55(5): 731 - 731. [Full Text] [PDF]
|
|
|
|
|
|
K. Kantarci, C. R. Jack Jr., Y. C. Xu, N. G. Campeau, P. C. O'Brien, G. E. Smith, R. J. Ivnik, B. F. Boeve, E. Kokmen, E. G. Tangalos, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study Neurology, July 25, 2000; 55(2): 210 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. I. Bolla, F. R. Funderburk, and J. L. Cadet Differential effects of cocaine and cocaine alcohol on neurocognitive performance Neurology, June 27, 2000; 54(12): 2285 - 2292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hock, K. Heese, F. Muller-Spahn, P. Huber, W. Riesen, R. M. Nitsch, and U. Otten Increased CSF levels of nerve growth factor in patients with Alzheimer's disease Neurology, May 23, 2000; 54(10): 2009 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nath, C. Anderson, M. Jones, W. Maragos, R. Booze, C. Mactutus, J. Bell, K. F. Hauser, and M. Mattson Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia J Psychopharmacol, May 1, 2000; 14(3): 222 - 227. [Abstract] [PDF]
|
|
|
|
 |
|
 X. Huang, M. P. Cuajungco, C. S. Atwood, R. D. Moir, R. E. Tanzi, and A. I. Bush Alzheimer's Disease, {beta}-Amyloid Protein and Zinc J. Nutr., May 1, 2000; 130(5): 1488S - 1492. [Abstract] [Full Text]
|
|
|
|
|
|
W.-L. van der Pol, L. H. van den Berg, R. H. M. Scheepers, J. G. van der Bom, P. A. van Doorn, R. van Koningsveld, M. C. L. van den Broek, J. H. J. Wokke, and J. G. J. van de Winkel IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barre syndrome Neurology, April 25, 2000; 54(8): 1661 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gelinas, S. Gauthier, and PamelaA. Cyrus Metrifonate Enhances the Ability of Alzheimer's Disease Patients to Initiate, Organize, and Execute Instrumental and Basic Activities of Daily Living J Geriatr Psychiatry Neurol, April 1, 2000; 13(1): 9 - 16. [Abstract] [PDF]
|
|
|
|
|
|
Y. Furukawa, O. Hornykiewicz, S. Fahn, and S. J. Kish Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation Neurology, March 14, 2000; 54(5): 1193 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Hartley, D. M. Walsh, C. P. Ye, T. Diehl, S. Vasquez, P. M. Vassilev, D. B. Teplow, and Dennis. J. Selkoe Protofibrillar Intermediates of Amyloid beta -Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons J. Neurosci., October 15, 1999; 19(20): 8876 - 8884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Martin Molecular Basis of the Neurodegenerative Disorders N. Engl. J. Med., June 24, 1999; 340(25): 1970 - 1980. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
